Selective up-regulation of CDK2 is critical for TLR9 signaling stimulated proliferation of human lung cancer cell

Immunology Letters

Volumn 127, Issue 2, 2010, Pages 93-99

  Xu, Lin ^a   Wang, Chunhong ^b   Wen, Zhenke ^c   Yao, Xinsheng ^a   Liu, Zhongmin ^d   Li, Qinchuan ^d   Wu, Zhenjun ^c   Xu, Zengguang ^d   Liang, Yongjie ^d   Ren, Tao ^d  

^a ZUNYI MEDICAL UNIVERSITY   (China)

^b Qingdao Chest Hospital   (China)

^c Qingdao Blood Center   (China)

^d TONGJI UNIVERSITY   (China)

Author keywords

95D cell; CDK2; CpG oligonucleotide; TLR9

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 3; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MATRIX METALLOPROTEINASE; TOLL LIKE RECEPTOR 9;

ARTICLE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR GROWTH; TUMOR PROMOTION; UPREGULATION;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; OLIGODEOXYRIBONUCLEOTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 9;

EID: 71949084146     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2009.10.002     Document Type: Article

References (24)

1. Gazzinelli R.T., and Denkers E.Y. Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. Nat Rev Immunol 6 12 (2006) 895-906
2. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27 8 (2006) 352-357
3. Meyer-Bahlburg A., Bandaranayake A.D., Andrews S.F., and Rawlings D.J. Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol 182 7 (2009) 4065-4075
4. Hasan U.A., Caux C., Perrot I., Doffin A.C., Menetrier-Caux C., Trinchieri G., et al. Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc Natl Acad Sci USA 104 19 (2007) 8047-8052
5. Thompson B.S., Mata-Haro V., Casella C.R., and Mitchell T.C. Peptide-stimulated DO11.10 T cells divide well but accumulate poorly in the absence of TLR agonist treatment. Eur J Immunol 35 11 (2005) 3196-3208
6. Huang B., Zhao J., Unkeless J.C., Feng Z.H., and Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27 2 (2008) 218-224
7. Chen R., Alvero A.B., Silasi D.A., Steffensen K.D., and Mor G. Cancers take their Toll-the function and regulation of Toll-like receptors in cancer cells. Oncogene 27 34 (2008) 225-233
8. Huang B., Zhao J., Li H., He K.L., Chen Y., Chen S.H., et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 65 12 (2005) 5009-5014
9. He W., Liu Q., Wang L., Chen W., Li N., and Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44 11 (2007) 2850-2859
10. Xu L., Zhou Y., Liu Q., Luo J.M., Qing M., Tang X.Y., et al. CXCR4/SDF-1 pathway is crucial for TLR9 agonist enhanced metastasis of human lung cancer cell. Biochem Biophys Res Commun 382 3 (2009) 571-576
11. Hua D., Liu M.Y., Cheng Z.D., Qin X.J., Zhang H.M., Chen Y., et al. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Mol Immunol July (2009) [Epub ahead of print]
12. Cowan C.R., and Hyman A.A. Cyclin E-Cdk2 temporally regulates centrosome assembly and establishment of polarity in Caenorhabditis elegans embryos. Nat Cell Biol 8 12 (2006) 1441-1447
13. Simmons Kovacs L.A., Orlando D.A., and Haase S.B. Transcription networks and cyclin/CDKs: the yin and yang of cell cycle oscillators. Cell Cycle 7 17 (2008) 2626-2629
14. Graf F., Koehler L., Kniess T., Wuest F., Mosch B., and Pietzsch J. Cell cycle regulating kinase Cdk4 as a potential target for tumor cell treatment and tumor imaging. J Oncol 2009 (2009) 106378
15. Malumbres M., and Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9 3 (2009) 153-166
16. Santamaria D., and Ortega S. Cyclins and CDKS in development and cancer: lessons from genetically modified mice. Front Biosci 11 (2006) 1164-1188
17. Ren T., Xu L., Jiao S., Wang Y., Cai Y., Liang Y., et al. TLR9 signaling promotes tumor progression of human lung cancer cell in vivo. Pathol Oncol Res (2009)
18. Droemann D., Albrecht D., Gerdes J., Ulmer A.J., Branscheid D., Vollmer E., et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res 6 (2005) 1
19. Jarrousse V., Quereux G., Marques-Briand S., Knol A.C., Khammari A., and Dreno B. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). Eur J Dermatol 16 6 (2006) 636-641
20. Ilvesaro J.M., Merrell M.A., Swain T.M., Davidson J., Zayzafoon M., Harris K.W., et al. Toll-like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 67 7 (2007) 774-781
21. Merrell M.A., Ilvesaro J.M., Lehtonen N., Sorsa T., Gehrs B., Rosenthal E., et al. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity. Mol Cancer Res 4 7 (2006) 437-447
22. Ren T., Wen Z.K., Liu Z.M., Liang Y.J., Guo Z.L., and Xu L. Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis. Cancer Biol Ther 6 11 (2008) 1704-1709
23. Hasan U.A., Trinchieri G., and Vlach J. Toll-like receptor signaling stimulates cell cycle entry and progression in fibroblasts. J Biol Chem 280 21 (2005) 20620-20627
24. Padmakumar V.C., Aleem E., Berthet C., Hilton M.B., and Kaldis P. Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53. Mol Cell Biol 29 10 (2009) 2582-2593